CASSANDRA ARVELO: Open Payments
NPI 1407510902 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 47 payments from 13 companies in 2025. Trend: 2023 $18 · 2024 $690 · 2025 $1,181
Food & beverage: $1,124Education: $57
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $458 |
| GlaxoSmithKline, LLC. | 17 | $304 |
| Optinose US, Inc. | 3 | $155 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Lilly USA, LLC | 2 | $35 |
| Stryker Corporation | 1 | $30 |
| Cochlear Americas | 1 | $25 |
| Smith+Nephew, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $20 |
Products named: DUPIXENT, NUCALA, Xhance, ZEPBOUND, AUDION ET DILATION SYSTEM, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, TULA, PROPEL.
Industry payments across NJ — which companies pay providers there.
